Table 1.
Demographic and clinical characteristics of the participants.
| LLD (n = 16) | Healthy (n = 30) | ||
|---|---|---|---|
| Depressed | Remitted | ||
| Age (years) | 56 [53.3–65.5] | 58 [54–67] | 58 [54–63.5] |
| Sex (Female %) | 10 (62.5%) | 19 (63.3%) | |
| Education (years) | 13 [12–15.8] | 14 [12–16] | |
| MMSE | 28.5 [26.3–30] | 30 [28.8–30] | |
| Age of onset (years) | 51 [33.5–59.8] | - | |
| Duration (years) | 7.5 [2.8–22.8] | 9.3 [4.9–24.6] | - |
| Number of episode | 2 [2–2] | - | |
| SIGH-Da,b | 20 [19–22.8] | 2 [0.3–4.8] | 1 [0–1] |
| GAFa,b | 51 [51–60] | 89.5 [81.3–90] | 90 [90–95] |
| IMP-eq (mg) | 143.8 [81.3–253.1] | 200 [81.3–309.4] | - |
Data represent median [inter-quartile range]. LLD, later-life depression; MMSE, Mini-mental state examination; SIGH-D, Structured Interview Guide for the Hamilton Rating for Depression Scale; GAF, Global Assessment of Functioning; IMP-eq., Imipramine equivalent. aDepressed vs. Remitted; p < 0.05 by Wilcoxon signed ranks test. bDepressed vs. Healthy; p < 0.05 by Mann-Whitney U test.